News
Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027.
Indianapolis-based pharmaceutical company Eli Lilly broke ground Tuesday on its $4.5 billion facility in Lebanon. The Lilly Medicine Foundry will be a research and development facility located at ...
Hosted on MSN2mon
Lilly breaks ground on $4.5 billion R&D facility - MSNBOONE COUNTY, Ind. (WISH) — Gov. Mike Braun and Eli Lilly officials broke ground Tuesday on one of the first major projects for the LEAP District. Company officials said the Lilly Medicine ...
Eli Lilly announces a $4.5B investment to build the Lilly Medicine Foundry, a state-of-the-art facility in Indiana. The new center will focus on advanced drug development and manufacturing ...
Plans for construction on a new Eli Lilly facility in Boone County are expected to move forward after the Lebanon City Council approved an agreement to provide water to the facility Monday night.
Eli Lilly to expand Durham operation with 100-job facility Pharma giant breaks ground on 600-job NC campus (Photos) Wake Tech's new RTP facility will produce workers for high-paying jobs ...
Eli Lilly has doubled its investment in its new Concord manufacturing facility from $1 billion to $2 billion since construction began in 2022, the company confirmed. The pharmaceutical giant ...
INDIANAPOLIS — Officials with Eli Lilly and Company announced Friday that the company plans to construct a new billion-dollar facility in Germany. According to a news release from the company… ...
Eli Lilly (NYSE:LLY) has agreed to acquire a manufacturing facility from Nexus Pharmaceuticals to further expand its global parenteral (injectable) product manufacturing network and support ...
Eli Lilly & Co. said Tuesday it will invest $700 million in a new facility in Boston aimed at developing RNA-based therapies. The company expects to have 250 scientists working at the site within ...
Eli Lilly said Wednesday it will invest $4.5 billion to build an advanced pharmaceutical drug manufacturing and development facility in Lebanon, Indiana expected to open in late 2027.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results